A batch of drugs stopped supplying in Guizhou involving Wyeth Pharmaceuticals, Southwest Pharmaceuticals, Suzhou Second Leaf and so on

On September 14, the Office of the Leading Group for The Central Procurement of Drugs in Guizhou Province issued a notice that some enterprises have been unable to guarantee the supply of drugs due to the transformation of production lines, production stoppages and other reasons, submitted an application for the cancellation of their products in the province's centralized procurement of drugs (hanging net) qualification, and promised that from the date of cancellation, the enterprise products of the same product regulations shall not participate in the centralized procurement activities of drugs in Guizhou Province for two years.
announcement, as of September 14, 2020, the winning bid (hanging net) for the drugs in the x image below will be disqualified.
at the same time, Guizhou Province requires medical institutions to cancel the winning bid (hanging net) qualified drugs, according to clinical needs to choose the procurement and use of similar products.
A total of 22 drugs on this list have been disqualified from winning the bid, including injections of amber, cephalosporinecapsules, raw pulse drinks, yew alcohol injections, including commonly used large varieties, involving Wyeth Pharmaceuticals, Taiji Group Chongqing Chinese Medicine Co., Ltd., Southwest Pharmaceuticals, Suzhou Diye Pharmaceutical Co., Ltd. and other well-known pharmaceutical companies.